ContextVision will have exclusive rights to the scanning cohort and access to anonymized associated clinical data - with cleared and structured histopathological descriptions, diagnosis and outcome data - for the defined patient cohorts and all commercial rights from output based on the data.The agreement gives ContextVision an opportunity to create AI-based decision support tools that will help doctors make more accurate treatment decisions. Today, many cancer patients suffer from life impairing side effects from treatments they did not need while other patients do not get treatment which is necessary.
Come and talk to our representatives about our upcoming digital pathology portfolio. Stand 22, London Heathrow Marriott Hotel.
September 6, 2018, – ContextVision is making their second appearance in the field of digital pathology at ECP 2018, the 30th European Congress of Pathology, September 8–12 in Bilbao, Spain. Here, they will be introducing and demonstrating their upcoming product INIFY™ Prostate, a new decision support tool based on artificial intelligence and deep learning.
ContextVision recently made their first appearance in the field of digital pathology at ECDP/NDP 2018 – the 14th European Congress on Digital Pathology and the 5th Nordic Symposium on Digital Pathology, held in Helsinki, Finland, end of May.
ContextVision will attend the 30th European Congress of Pathology (ECP 2018) in Bilbao, Spain. Come and talk to our representatives about our upcoming digital pathology portfolio. Stand 43, hall I + II on level -2 in the Euskalduna Conference Centre
June 20, 2018 – The installation was made through the fully integration with the Hospital's Laboratory Information System at the pathology department at Ospedale Cannizzaro in Catania, Italy.
May 28, 2018, – ContextVision will be introducing their upcoming product INIFY™ Prostate, a new decision support tool based on artificial intelligence and deep learning.
ContextVision and its academic partners at Uppsala University and Uppsala Hospital have been awarded a grant from Sweden's innovation agency, Vinnova, for a continuation of a research program within digital pathology research. The company has already achieved very encouraging results in preliminary studies. The grant will cover costs at the hospital and at Uppsala University.
ContextVision reaches another top position in a prestigious competition using deep learning in digital pathology
ContextVision placed second in a renowned international competition on automated image analysis called the Camelyon Challenge.
Stand 04, Clarion Hotel Helsinki, Tyynenmerenkatu 2, 00220 Helsinki, Finland. Contact us: Lena Kajland Wilén / Director Business Unit Digital Pathology, phone: +46 70 629 07 84 or e-mail: